Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan

INTRODUCTION: This study described, in routine clinical practice in Japan, the patient characteristics, treatment patterns, and outcomes of female patients with HR + /HER2- metastatic breast cancer (MBC) who started abemaciclib treatment. METHODS: Clinical charts were reviewed for patients starting...

Descripción completa

Detalles Bibliográficos
Autores principales: Nozawa, K., Terada, M., Onishi, M., Ozaki, Y., Takano, T., Fakhouri, W., Novick, D., Haro, J. M., Faris, L. H., Kawaguchi, T., Tanizawa, Y., Tsurutani, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284953/
https://www.ncbi.nlm.nih.gov/pubmed/37217763
http://dx.doi.org/10.1007/s12282-023-01461-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284953/
https://www.ncbi.nlm.nih.gov/pubmed/37217763
http://dx.doi.org/10.1007/s12282-023-01461-6

Ejemplares similares